Genmab A/S S/Adr

(GMXAY)

By |

Profile

Genmab A/S is an antibody company focused on cancer. Its first marketed product is Arzerra (ofatumumab); development pipeline incl. daratumumab and two proprietary technology platforms; DuoBody (bispecifics) & HexaBody (effector function enhancement).

Contact Information

Website: www.genmab.com
Main Phone: +45 70202728
Address: Bredgade 34E
City / Town: Copenhagen K
Country: DNK
Postal Code: 1260

Issuer Information

Exchange: OTO
Employees: 189
$ 103.06 $ -1.26 (-1.21%)
Last Price 103.06 Change $ -1.26 Change % -1.21 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 103.06 High 103.06 Low 103.06 Prev Close 104.32
Last Trade Volume 530 52 Wk Hi 117.75 52 Wk Low 81.05
Market Cap 12.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 122,362,484.00 EPS (TTM) 1.42 PE Ratio 73.50 Exchange OTCPK